Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 12455 [2017-04102]

Download as PDF Federal Register / Vol. 82, No. 41 / Friday, March 3, 2017 / Notices affiliation, mailing address, telephone number, email address). • Letter(s) of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. Contact Person for More Information: Nancy Anderson, Chief, Laboratory Practice Standards Branch, Division of Laboratory Systems, Center for Surveillance, Epidemiology and Laboratory Services, Office of Public Health Scientific Services, Centers for Disease Control and Prevention, 1600 Clifton Road, NE., Mailstop F–11, Atlanta, Georgia 30329–4018; telephone (404) 498–2741; or via email at NAnderson@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Cooperative Research Agreements to the World Trade Center Health Program (U01)’’, PAR 16–098. Contact Person for More Information: Nina Turner, Ph.D., Scientific Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, Morgantown, West Virginia 26505, Telephone: (304) 285–5975. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2017–04102 Filed 3–2–17; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2017–04103 Filed 3–2–17; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention mstockstill on DSK3G9T082PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA), PAR 16–098 Cooperative Research Agreements to the World Trade Center Health Program (U01). Times and Dates: 8:00 a.m.–5:00 p.m., EDT, March 28, 2017 (Closed) 8:00 a.m.–12:00 p.m., EDT, March 29, 2017(Closed) Place: Courtyard Marriott Decatur Downtown/Emory, 130 Clairemont Avenue, Decatur, Georgia 30030, Telephone: (404)371–0204. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, VerDate Sep<11>2014 16:42 Mar 02, 2017 Jkt 241001 Request for Nominations of Candidates To Serve on the Mine Safety and Health Research Advisory Committee (MSHRAC), National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention (CDC), Department of Health and Human Services The CDC is soliciting nominations for possible membership on the Mine Safety and Health Research Advisory Committee (MSHRAC), National Institute for Occupational Safety and Health (NIOSH). The MSHRAC consists of 13 experts in fields related to mining safety and health. The members are selected by the Secretary of the U.S. Department of Health and Human Services (HHS). The committee advises the NIOSH Director on mining safety and health research and prevention programs. The committee also provides advice on standards of scientific excellence, current needs in the field of mining safety and health, and the applicability and dissemination of research findings. This advice may take the form of reports PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 12455 or verbal communications to the NIOSH Director during MSHRAC meetings. Nominations are being sought for individuals who have expertise and qualifications necessary to contribute to the accomplishment of the committee’s mission. Nominees will be selected based on expertise in the field of mining safety and health, such as mining engineering, industrial hygiene, occupational safety and health engineering, chemistry, safety and health education, ergonomics, epidemiology, statistics, and psychology. Members may be invited to serve for terms of up to four years. The U.S. Department of Health and Human Services policy stipulates that Committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens, and cannot be full-time employees of the U.S. Government. Current participation on federal workgroups or prior experience serving on a federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for the MSHRAC membership each year, and provides a slate of nominees for consideration to the Secretary of HHS for final selection. Candidates should submit the following items: • Current curriculum vitae, including complete contact information (name, affiliation, mailing address, telephone number, email address) • A letter of recommendation stating the qualifications of the candidate. Nomination materials must be postmarked by April 30, 2017, and sent to: Jeffrey H. Welsh, Designated Federal Officer for MSHRAC, NIOSH, CDC, 626 Cochrans Mill Road, Pittsburgh, PA 15236, telephone (412) 386–4040. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for the Centers for Disease Control and Prevention and E:\FR\FM\03MRN1.SGM 03MRN1

Agencies

[Federal Register Volume 82, Number 41 (Friday, March 3, 2017)]
[Notices]
[Page 12455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04102]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA), PAR 
16-098 Cooperative Research Agreements to the World Trade Center Health 
Program (U01).
    Times and Dates:
8:00 a.m.-5:00 p.m., EDT, March 28, 2017 (Closed)
8:00 a.m.-12:00 p.m., EDT, March 29, 2017(Closed)
    Place: Courtyard Marriott Decatur Downtown/Emory, 130 Clairemont 
Avenue, Decatur, Georgia 30030, Telephone: (404)371-0204.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to ``Cooperative Research Agreements to the World Trade Center Health 
Program (U01)'', PAR 16-098.
    Contact Person for More Information: Nina Turner, Ph.D., Scientific 
Review Officer, CDC/NIOSH, 1095 Willowdale Road, Mailstop G905, 
Morgantown, West Virginia 26505, Telephone: (304) 285-5975.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-04102 Filed 3-2-17; 8:45 am]
 BILLING CODE 4163-18-P